Introduction: Viral hepatitis B represents a major public health problem in the world. Vertical transmission has been identified as one of the causes of the high prevalence of hepatitis B virus infection in sub-Saharan Africa. Pregnant women carrying the virus expose their offspring to infection. The aim of this study was to determine the prevalence of viral hepatitis B in pregnant women. Methods: This descriptive cross-sectional study included pregnant women seen at the prenatal consultation (PNC). The data were collected by means of a questionnaire sent to each respondent included in the study. Statistical processing and analysis of the data collected was done using SPSS 2.1 software. Bivariate analysis was used to study the relationships between the dependent variables and the explanatory variables. HBsAg testing was performed by a rapid diagnostic bioassay. Results: A total of 266 pregnant women participated in the study. The mean age was 25.62 ± 5.17 years, with extremes of 18 and 41 years. The majority (51.9%) had been tested for HBsAg during the prenatal consultation, of which 10.1% (n=14) tested positive. There was no statistically significant relationship between HBsAg carriage and monthly income of pregnant women. Similarly, there was no statistically significant relationship between HBsAg carriage or not and the existence of a family member with hepatitis B. Conclusion: In light of our results, it is important to develop effective control strategies. There is a need to sensitize women of childbearing age in order to reduce the risk of HBV transmission from mother to child.
Published in | American Journal of Health Research (Volume 10, Issue 4) |
DOI | 10.11648/j.ajhr.20221004.14 |
Page(s) | 175-178 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Prevalence, Pregnant Women, Viral Hepatitis B, HBsAg, Chad
[1] | World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015; 166. |
[2] | Meffre C, Le Srat Y, Delaroque-Astagneau E, Antona D, Desenclos JC. Prévalence des hépatites B et C en France en 2004. Institut de veille sanitaire, Saint-Maurice, mars 2007. 114p. [Prevalence of hepatitis B and C in France in 2004. Institut de veille sanitaire, Saint-Maurice, March 2007]. |
[3] | Aubry P, Gaüzère BA. Hépatites virales en zones tropicales. 2018, Med. Trop (Mars.), p. 4. [Viral hepatitis in tropical areas. 2018, Med]. |
[4] | Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005; 34 (6); 1329-1339. |
[5] | Borchardt SM, Kocharian A, Hopfensperger D, Davis JP. Prevention of perinatal transmission of hepatitis B virus: assessment among Wisconsin Maternity Hospitals. WMJ Off Publ State Med Soc Wis. 2016; 115 (2): 74-79. |
[6] | Pande C, Sarin S K, Patra S, Kumar A, Mishra S, Srivastava S et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat. 2013; 20 (11): 801-810. |
[7] | Global hepatitis report. Geneva: World Health Organization; 2017. Available from: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ [cited 2019 Jun 19]. |
[8] | Organisation mondiale de la Santé. Vaccins anti-hépatite B; note de synthèse de l’OMS - juillet 2017. Relevé épidémiologique hebdomadaire 92 (17); 369–392; 2017 (http://apps.who.int/iris/bitstream/10665/255841/1/WER9227). [WHO briefing note - July 2017. Weekly Epidemiological Record]. |
[9] | Khadidjatou SA, Rachidi SI, Honorat S. Séroprévalence et facteurs associés à l'hépatite virale B chez les gestantes à Parakou en République du Bénin, The Pan African Medical Journal; pamj.2019.33.226.19429. [Seroprevalence and factors associated with viral hepatitis B in pregnant women in Parakou, Republic of Benin]. |
[10] | Bessimbaye N, Moussa A, Mbanga, Tidjani A. Séroprévalence de l’AgHBs et de l’anticorps Anti VHC chez les personnes infectées par le VIH1 à N’Djamena, Tchad. 2014. Bull Soc Pathol Exot. 2014; 10 (7); 327-31. [Seroprevalence of HBsAg and Anti-HCV antibody among HIV1 infected persons in N'Djamena, Chad. 2014]. |
[11] | Mawouma ARN, Djoulatou AH, Komnang EO, Kimessoukie EO. Facteurs associés à l’infection de l’hépatite B chez les femmes enceintes dans les formations sanitaires du district de santé de Mokolo/Région de l’Extrême-Nord Cameroun. PAMJ – 41 (61). 21 Jan 2022. [Factors associated with hepatitis B infection among pregnant women in the health facilities of the Mokolo Health District/Far North Region of Cameroon]. |
[12] | World Health Organization W: Hepatitis B Fact Sheet In.: WHO; 2008: 204. |
[13] | Njoya O, Essi MJ, Ongolo B, Obama MT. Connaissances, Perceptions et Pratiques des Femmes Enceintes Vis à vis de l’Hépatite Virale B en Milieu Urbain au Cameroun. Health Sci. Dis: Vol 14 (2) June 2013. [Knowledge, Perceptions and Practices of Pregnant Women Towards Viral Hepatitis B in Urban Cameroon]. |
[14] | Tatsi S. Connaissances, perceptions et pratiques des femmes enceintes vis à vis de l'hépatite virale B Etude pilote à l'hôpital général de Marcory-Abidjan en 2014; 2014 UFR des Sciences Médicales-UFHB Abidjan [Knowledge, perceptions and practices of pregnant women regarding viral hepatitis B Pilot study in the general hospital of Marcory-Abidjan in 2014]. |
[15] | Latthaphasavang V. Suivi prospectif d’une cohorte des femmes enceintes chroniquement infectées par le virus de l’hépatite B (VHB) et leurs en enfants en RDP Laos. Virologie, Université de Lyon, 2018. [Prospective follow-up of a cohort of chronically hepatitis B virus (HBV)-infected pregnant women and their children in Lao PDR. Virology, University of Lyon, 2018]. |
[16] | INSEED. Enquête Démographique et de santé et à indicateurs Multiples au Tchad (EDS-MICS) 2014-2015. 2016. [Chad Demographic and Health Survey and Multiple Indicator Cluster Survey]. |
APA Style
Mayanna Habkreo, Ali Mahamat Moussa, Tahir Mahamat Saleh, Maire Dehainssala, Adama Ngare, et al. (2022). Prevalence of Viral Hepatitis B Among Pregnant Women in N'Djamena. American Journal of Health Research, 10(4), 175-178. https://doi.org/10.11648/j.ajhr.20221004.14
ACS Style
Mayanna Habkreo; Ali Mahamat Moussa; Tahir Mahamat Saleh; Maire Dehainssala; Adama Ngare, et al. Prevalence of Viral Hepatitis B Among Pregnant Women in N'Djamena. Am. J. Health Res. 2022, 10(4), 175-178. doi: 10.11648/j.ajhr.20221004.14
@article{10.11648/j.ajhr.20221004.14, author = {Mayanna Habkreo and Ali Mahamat Moussa and Tahir Mahamat Saleh and Maire Dehainssala and Adama Ngare and Moussa Elefi}, title = {Prevalence of Viral Hepatitis B Among Pregnant Women in N'Djamena}, journal = {American Journal of Health Research}, volume = {10}, number = {4}, pages = {175-178}, doi = {10.11648/j.ajhr.20221004.14}, url = {https://doi.org/10.11648/j.ajhr.20221004.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20221004.14}, abstract = {Introduction: Viral hepatitis B represents a major public health problem in the world. Vertical transmission has been identified as one of the causes of the high prevalence of hepatitis B virus infection in sub-Saharan Africa. Pregnant women carrying the virus expose their offspring to infection. The aim of this study was to determine the prevalence of viral hepatitis B in pregnant women. Methods: This descriptive cross-sectional study included pregnant women seen at the prenatal consultation (PNC). The data were collected by means of a questionnaire sent to each respondent included in the study. Statistical processing and analysis of the data collected was done using SPSS 2.1 software. Bivariate analysis was used to study the relationships between the dependent variables and the explanatory variables. HBsAg testing was performed by a rapid diagnostic bioassay. Results: A total of 266 pregnant women participated in the study. The mean age was 25.62 ± 5.17 years, with extremes of 18 and 41 years. The majority (51.9%) had been tested for HBsAg during the prenatal consultation, of which 10.1% (n=14) tested positive. There was no statistically significant relationship between HBsAg carriage and monthly income of pregnant women. Similarly, there was no statistically significant relationship between HBsAg carriage or not and the existence of a family member with hepatitis B. Conclusion: In light of our results, it is important to develop effective control strategies. There is a need to sensitize women of childbearing age in order to reduce the risk of HBV transmission from mother to child.}, year = {2022} }
TY - JOUR T1 - Prevalence of Viral Hepatitis B Among Pregnant Women in N'Djamena AU - Mayanna Habkreo AU - Ali Mahamat Moussa AU - Tahir Mahamat Saleh AU - Maire Dehainssala AU - Adama Ngare AU - Moussa Elefi Y1 - 2022/08/24 PY - 2022 N1 - https://doi.org/10.11648/j.ajhr.20221004.14 DO - 10.11648/j.ajhr.20221004.14 T2 - American Journal of Health Research JF - American Journal of Health Research JO - American Journal of Health Research SP - 175 EP - 178 PB - Science Publishing Group SN - 2330-8796 UR - https://doi.org/10.11648/j.ajhr.20221004.14 AB - Introduction: Viral hepatitis B represents a major public health problem in the world. Vertical transmission has been identified as one of the causes of the high prevalence of hepatitis B virus infection in sub-Saharan Africa. Pregnant women carrying the virus expose their offspring to infection. The aim of this study was to determine the prevalence of viral hepatitis B in pregnant women. Methods: This descriptive cross-sectional study included pregnant women seen at the prenatal consultation (PNC). The data were collected by means of a questionnaire sent to each respondent included in the study. Statistical processing and analysis of the data collected was done using SPSS 2.1 software. Bivariate analysis was used to study the relationships between the dependent variables and the explanatory variables. HBsAg testing was performed by a rapid diagnostic bioassay. Results: A total of 266 pregnant women participated in the study. The mean age was 25.62 ± 5.17 years, with extremes of 18 and 41 years. The majority (51.9%) had been tested for HBsAg during the prenatal consultation, of which 10.1% (n=14) tested positive. There was no statistically significant relationship between HBsAg carriage and monthly income of pregnant women. Similarly, there was no statistically significant relationship between HBsAg carriage or not and the existence of a family member with hepatitis B. Conclusion: In light of our results, it is important to develop effective control strategies. There is a need to sensitize women of childbearing age in order to reduce the risk of HBV transmission from mother to child. VL - 10 IS - 4 ER -